Jeff Yass’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.33M Buy
481,600
+86,300
+22% +$528K ﹤0.01% 4489
2026
Q1
$3.02M Buy
395,300
+144,300
+57% +$1.1M ﹤0.01% 5248
2025
Q4
$2.44M Sell
251,000
-1,477,800
-85% -$12.6M ﹤0.01% 5230
2025
Q3
$7.24M Buy
1,728,800
+1,612,100
+1,381% +$10.3M ﹤0.01% 3502
2025
Q2
$1.08M Sell
116,700
-36,300
-24% -$317K ﹤0.01% 7212
2025
Q1
$1.49M Buy
153,000
+112,800
+281% +$1.4M ﹤0.01% 6232
2024
Q4
$487K Buy
+40,200
New +$488K ﹤0.01% 8729
2024
Q3
Sell
-24,400
Closed -$220K 12856
2024
Q2
$220K Sell
24,400
-50,000
-67% -$348K ﹤0.01% 10152
2024
Q1
$608K Buy
74,400
+41,700
+128% +$342K ﹤0.01% 8046
2023
Q4
$276K Sell
32,700
-285,500
-90% -$3.31M ﹤0.01% 10003
2023
Q3
$5.44M Buy
318,200
+157,500
+98% +$3.09M ﹤0.01% 3372
2023
Q2
$3.73M Buy
+160,700
New +$3.14M ﹤0.01% 4010
2021
Q3
Sell
-19,500
Closed -$749K 13418
2021
Q2
$749K Sell
19,500
-14,600
-43% -$499K ﹤0.01% 8561
2021
Q1
$1.04M Buy
34,100
+7,300
+27% +$273K ﹤0.01% 7636
2020
Q4
$1.02M Buy
+26,800
New +$1.12M ﹤0.01% 6679

Other funds holding REPL

Jeff Yass's REPL Position: Q2 2026 in Review

Jeff Yass reduced its Replimune Group (REPL) stake by 59% in Q2 2026, selling an estimated $2.27M and leaving 253,450 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #5770.

Jeff Yass first reported a position in REPL in Q4 2020 and has held it in 21 quarters since. The position peaked at $5.9M in Q4 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Jeff Yass held 253,450 shares of Replimune Group worth $2.81M as of Q2 2026.
  • Jeff Yass sold 370,529 Replimune Group shares in Q2 2026, an estimated $2.27M.
  • Replimune Group made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5770 holding.
  • Jeff Yass first reported a position in Replimune Group in Q4 2020 and has held it in 21 quarters since.
  • Jeff Yass's Replimune Group position peaked at $5.9M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.